SCHEMBL7066015

SCHEMBL7066015

Cc1ccc(S(=O)(=O)ON(N=Cc2cc(Cl)ccc2[N+](=O)[O-])C(=N)N)cc1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.38
MEN1 O00255 4/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
HPGD P15428 2/20 0.38
PSMD14 O00487 1/20 0.38
BLM P54132 1/20 0.38
MAPT P10636 10/20 0.38
LMNA P02545 7/20 0.38
TDP1 Q9NUW8 3/20 0.38
HTT P42858 1/20 0.38
F2 P00734 3/20 0.36
PRSS1 P07477 3/20 0.36
PRSS2 P07478 3/20 0.36
PRSS3 P35030 3/20 0.36
ALDH1A1 P00352 7/20 0.36
L3MBTL1 Q9Y468 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
POLB P06746 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7064452 0.88 MAPT (0.41) KMT2AMEN1SMN1; SMN2MAPTLMNA
SCHEMBL7065013 0.83 ALDH1A1 (0.39) KMT2AMEN1SMN1; SMN2MAPTLMNA
SCHEMBL7066729 0.83 ALDH1A1 (0.53) KMT2AMEN1SMN1; SMN2MAPTLMNA
SCHEMBL7064848 0.83 ALDH1A1 (0.39) KMT2AMEN1SMN1; SMN2MAPTLMNA
SCHEMBL7065975 0.83 MAPT (0.39) KMT2AMEN1SMN1; SMN2MAPTLMNA
SCHEMBL7066013 0.82 MAPT (0.39) KMT2AMEN1SMN1; SMN2HPGDPSMD14
SCHEMBL7066011 0.82 MAPT (0.39) KMT2AMEN1SMN1; SMN2HPGDPSMD14
SCHEMBL7062996 0.82 MAPT (0.38) KMT2AMEN1SMN1; SMN2MAPTLMNA
SCHEMBL7065379 0.81 MAPT (0.42) KMT2AMEN1SMN1; SMN2BLMMAPT
SCHEMBL7062256 0.81 ALDH1A1 (0.41) KMT2AMEN1SMN1; SMN2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313461-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS Melacure Therapeutics AB (SE) 2003-05-28 EP disclosed
WO-2002011715-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS MELACURE THERAPEUTICS AB (SE) 2002-02-14 WO disclosed